Alan Forrest, Pharm.D.
Senior Scientist, Pharmacometrics, ICPD · Ordway Research Institute
Research Professor, Schools of Pharmacy and Pharmaceutical Sciences, and of Medicine and Biomedical Sciences, University at Buffalo
Special Government Employee, Expert in population Pharmacokinetic-Pharmacodynamic Analysis, Office of Clinical Pharmacology and Biopharmaceutics, Center for Drug Evaluation and Research, Food and Drug Administration, Department of Health and Human Services
Telephone: (716) 645-2828, ext. 227
Fax: (518) 641-6303
E-mail: AForrest-ICPD@OrdwayResearch.org
Research Focus
Dr. Forrest completed his Doctorate in Pharmacy in 1979 at the University of Southern California. He was a Post Graduate Research Scholar, in Clinical Pharmacology, in Roger Jelliffe’s Laboratory of Applied Pharmacokinetics, at the USC School of Medicine. Dr. Forrest then became a Faculty Member, at the University of Southern California Pharmacy and of Medicine. He was at the University of Maryland in Baltimore, Schools of Pharmacy and of Medicine, as an Assistant Professor (Clinical Pharmacy, Infectious Diseases and Oncology) from 1982 to 1989 and has been at the State University of New York at Buffalo, Schools of Pharmacy and of Medicine, since 1989.
Dr. Forrest’s main expertise is in pharmacometrics (advanced applications of PK-PD system analysis). His research spans all drug classes but has emphasized infectious diseases and oncology. His special research interests are in clinical and research applications of adaptive feedback control in the optimization of drug therapy, individual and population PK-PD modeling, translational PK-PD research in drug development and development and validation of optimal PK-PD study designs.
Dr. Forrest is author or co-author on 5 book chapters and 130 publications in peer-reviewed journals. He has made 58 invited presentations and he is author or co-author on 287 peer-reviewed abstracts, at national and international symposia. He has presented numerous other invited presentations, at the Food and Drug Administration, the National Institutes for Health, Universities, pharmaceutical companies, and others.